
Hypercholesterolemia Global Market Report 2025
Description
Hypercholesterolemia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hypercholesterolemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for hypercholesterolemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hypercholesterolemia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Disease Type: Genetic; Acquired
2) By Treatment: Statins; Bile Acid Resins; Niacin; PCSK9 Inhibitors; Cholesterol Absorption Inhibitors; Fibric Acid Derivatives; Other Treatments
3) By Route Of Administration: Oral; Injectable
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Others Distribution Channel
5) By End User: Hospitals; Specialty Clinics; Home Healthcare; Others End Users
Subsegments:
1) By Genetic: Heterozygous Familial Hypercholesterolemia; Homozygous Familial Hypercholesterolemia
2) By Acquired: Primary Hypercholesterolemia; Secondary Hypercholesterolemia
Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Abbvie Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on hypercholesterolemia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hypercholesterolemia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hypercholesterolemia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Disease Type: Genetic; Acquired
2) By Treatment: Statins; Bile Acid Resins; Niacin; PCSK9 Inhibitors; Cholesterol Absorption Inhibitors; Fibric Acid Derivatives; Other Treatments
3) By Route Of Administration: Oral; Injectable
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Others Distribution Channel
5) By End User: Hospitals; Specialty Clinics; Home Healthcare; Others End Users
Subsegments:
1) By Genetic: Heterozygous Familial Hypercholesterolemia; Homozygous Familial Hypercholesterolemia
2) By Acquired: Primary Hypercholesterolemia; Secondary Hypercholesterolemia
Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Abbvie Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Hypercholesterolemia Market Characteristics
- 3. Hypercholesterolemia Market Trends And Strategies
- 4. Hypercholesterolemia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Hypercholesterolemia Growth Analysis And Strategic Analysis Framework
- 5.1. Global Hypercholesterolemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Hypercholesterolemia Market Growth Rate Analysis
- 5.4. Global Hypercholesterolemia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Hypercholesterolemia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Hypercholesterolemia Total Addressable Market (TAM)
- 6. Hypercholesterolemia Market Segmentation
- 6.1. Global Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic
- Acquired
- 6.2. Global Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Statins
- Bile Acid Resins
- Niacin
- PCSK9 Inhibitors
- Cholesterol Absorption Inhibitors
- Fibric Acid Derivatives
- Other Treatments
- 6.3. Global Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- 6.4. Global Hypercholesterolemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Others Distribution Channel
- 6.5. Global Hypercholesterolemia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others End Users
- 6.6. Global Hypercholesterolemia Market, Sub-Segmentation Of Genetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Heterozygous Familial Hypercholesterolemia
- Homozygous Familial Hypercholesterolemia
- 6.7. Global Hypercholesterolemia Market, Sub-Segmentation Of Acquired, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Hypercholesterolemia
- Secondary Hypercholesterolemia
- 7. Hypercholesterolemia Market Regional And Country Analysis
- 7.1. Global Hypercholesterolemia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Hypercholesterolemia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Hypercholesterolemia Market
- 8.1. Asia-Pacific Hypercholesterolemia Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Hypercholesterolemia Market
- 9.1. China Hypercholesterolemia Market Overview
- 9.2. China Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Hypercholesterolemia Market
- 10.1. India Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Hypercholesterolemia Market
- 11.1. Japan Hypercholesterolemia Market Overview
- 11.2. Japan Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Hypercholesterolemia Market
- 12.1. Australia Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Hypercholesterolemia Market
- 13.1. Indonesia Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Hypercholesterolemia Market
- 14.1. South Korea Hypercholesterolemia Market Overview
- 14.2. South Korea Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Hypercholesterolemia Market
- 15.1. Western Europe Hypercholesterolemia Market Overview
- 15.2. Western Europe Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Hypercholesterolemia Market
- 16.1. UK Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Hypercholesterolemia Market
- 17.1. Germany Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Hypercholesterolemia Market
- 18.1. France Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Hypercholesterolemia Market
- 19.1. Italy Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Hypercholesterolemia Market
- 20.1. Spain Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Hypercholesterolemia Market
- 21.1. Eastern Europe Hypercholesterolemia Market Overview
- 21.2. Eastern Europe Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Hypercholesterolemia Market
- 22.1. Russia Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Hypercholesterolemia Market
- 23.1. North America Hypercholesterolemia Market Overview
- 23.2. North America Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Hypercholesterolemia Market
- 24.1. USA Hypercholesterolemia Market Overview
- 24.2. USA Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Hypercholesterolemia Market
- 25.1. Canada Hypercholesterolemia Market Overview
- 25.2. Canada Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Hypercholesterolemia Market
- 26.1. South America Hypercholesterolemia Market Overview
- 26.2. South America Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Hypercholesterolemia Market
- 27.1. Brazil Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Hypercholesterolemia Market
- 28.1. Middle East Hypercholesterolemia Market Overview
- 28.2. Middle East Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Hypercholesterolemia Market
- 29.1. Africa Hypercholesterolemia Market Overview
- 29.2. Africa Hypercholesterolemia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Hypercholesterolemia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Hypercholesterolemia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Hypercholesterolemia Market Competitive Landscape And Company Profiles
- 30.1. Hypercholesterolemia Market Competitive Landscape
- 30.2. Hypercholesterolemia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 31. Hypercholesterolemia Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc (GSK)
- 31.4. Eli Lilly and Company
- 31.5. Amgen Inc.
- 31.6. Viatris Inc.
- 31.7. Aegerion Pharmaceuticals Inc.
- 31.8. Fresenius Kabi AG
- 31.9. Sun Pharmaceutical Industries Ltd.
- 31.10. Chiesi Farmaceutici S.p.A.
- 31.11. Aurobindo Pharma Limited
- 31.12. Dr. Reddy's Laboratories Ltd.
- 31.13. Lupin Limited
- 31.14. Ionis Pharmaceuticals Inc.
- 31.15. Melinta Therapeutics Inc.
- 32. Global Hypercholesterolemia Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Hypercholesterolemia Market
- 34. Recent Developments In The Hypercholesterolemia Market
- 35. Hypercholesterolemia Market High Potential Countries, Segments and Strategies
- 35.1 Hypercholesterolemia Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Hypercholesterolemia Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Hypercholesterolemia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.